These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15800804)

  • 1. Drug repurposing: identify, develop and commercialize new uses for existing or abandoned drugs. Part I.
    Carley DW
    IDrugs; 2005 Apr; 8(4):306-9. PubMed ID: 15800804
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug repurposing: identify, develop and commercialize new uses for existing or abandoned drugs. Part II.
    Carley DW
    IDrugs; 2005 Apr; 8(4):310-3. PubMed ID: 15800805
    [No Abstract]   [Full Text] [Related]  

  • 3. Viewpoint: pharmaceutical innovation in Europe.
    Baines E
    Circulation; 2007 Jan; 115(2):f5-6. PubMed ID: 17228009
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in the development of chiral drugs.
    Caner H; Groner E; Levy L; Agranat I
    Drug Discov Today; 2004 Feb; 9(3):105-10. PubMed ID: 15038394
    [No Abstract]   [Full Text] [Related]  

  • 5. Three-dimensional drugs: A new era in the pharmaceutical development.
    Kumar H; Prakash A; Sarma P; Medhi B
    Indian J Pharmacol; 2017; 49(6):417-418. PubMed ID: 29674795
    [No Abstract]   [Full Text] [Related]  

  • 6. The economics of drug development: a grim reality and a role for clinical pharmacology.
    Honig P; Lalonde R
    Clin Pharmacol Ther; 2010 Mar; 87(3):247-51. PubMed ID: 20160740
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of solid-state NMR in pharmaceutical analysis.
    Vogt FG
    Future Med Chem; 2010 Jun; 2(6):915-21. PubMed ID: 21426109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future perspectives in pharmaceutics: contributions from younger scientists. Preface.
    Siepmann J
    Int J Pharm; 2008 Dec; 364(2):157-8. PubMed ID: 18929633
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology partnerships--medicine for an ailing industry?
    DeLamarter J
    Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
    [No Abstract]   [Full Text] [Related]  

  • 10. Current product equivalency issues.
    Gerrard TL
    Food Drug Law J; 1995; 50(3):451-3. PubMed ID: 10343011
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Novel formulation strategies for poorly water-soluble drugs and herbal medicines.
    Zheng Y
    Curr Pharm Des; 2014; 20(3):301-2. PubMed ID: 23651404
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advancing applications of microarrays.
    Pluskal MG; Bachmann J
    Drug Discov Today; 2004 Jan; 9(2):61-3. PubMed ID: 15012929
    [No Abstract]   [Full Text] [Related]  

  • 14. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing.
    Rantanen J; Khinast J
    Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of drugs that interact with herbs in drug development.
    Zhou SF; Zhou ZW; Li CG; Chen X; Yu X; Xue CC; Herington A
    Drug Discov Today; 2007 Aug; 12(15-16):664-73. PubMed ID: 17706549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous processing and the applications of online tools in pharmaceutical product manufacture: developments and examples.
    Ooi SM; Sarkar S; van Varenbergh G; Schoeters K; Heng PW
    Ther Deliv; 2013 Apr; 4(4):463-70. PubMed ID: 23557287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second-Generation Pharmaceutical Proteins-EUFEPS Workshop on Optimizing Biotech Medicines.
    Pasut G; Veronese FM
    IDrugs; 2007 Mar; 10(3):162-4. PubMed ID: 17351866
    [No Abstract]   [Full Text] [Related]  

  • 19. Guiding molecules towards drug-likeness.
    Egan WJ; Walters WP; Murcko MA
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):540-9. PubMed ID: 12197312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future DDS by qualified science of science for hybrid, hi-quality and husbandry.
    Nagai T
    J Drug Target; 2006; 14(7):446-7. PubMed ID: 17062390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.